Breast Cancer Awareness
Sara M. Tolaney, MD, MPH
Tolaney reports consulting or advising for Aadi Bio, ARC Therapeutics, Artios Biopharmaceuticals, Arvinas, AstraZeneca, Bayer, BeyondSpring Pharmaceuticals, BioNTech, Blueprint Medicines, Bristol-Myers Squibb/Systimmune, Circle Pharma, Cullinan Pharmaceutical, CytomX, Daiichi Sankyo, eFFECTOR, Eisai, Eli Lilly, Genentech/Roche, Gilead, Hengrui Pharmaceutical USA, Incyte Corp, Jazz Pharmaceuticals, Johnson&Johnson/AMBRX, Launch Therapeutics, Menarini/Stemline, Merck, Natera, Novartis, Pfizer, Reveal Genomics, Sanofi, Seattle Genetics, Sumitovant, Tango Therapeutics, Umoja Biopharma, Zentalis, Zuellig Pharmaceuticals and Zymeworks; and receiving research funding from AstraZeneca, Bristol-Myers Squiqq/Systimmune, Cyclacel, Genentech/Roche, Gilead, Eisai, Eli Lilly, Exelixis, Menarini/Stemline, Merck, Nanostring, Novartis, OncoPep, Pfizer, Sanofi and Seattle Genetics.
VIDEO: Rising breast cancer incidence impacts awareness yet ‘there is a need to do better’
Transcript
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
You know, incidents of breast cancer unfortunately has been rising, and we see that currently about one in eight women are diagnosed with breast cancer in their lifetime. And that is only increasing at about a rate of 1% per year. And so this is a problem, and one that I think we do need to address in terms of why is these incidences increasing. It tends to also be increasing in our younger patients, and in minority populations. And so, you know, I think seeing this rise has led to an effort to make patients more aware of breast cancer, hopefully make patients more aware of the critical need for screening at an early age, so that we can detect cancers earlier, where they're more likely to be cured. You know, I think, again, it's been improving, but clearly there is a need to do better, as we certainly do see there are lots of patients who are not getting the screening that they need to be getting. I hope we can do better in educating our community about the importance of that.
